Health Care: Drugs

Achillion Pharmaceuticals Inc (ACHN: NASDAQ)

$12.27 0.7 | 6.05%
09/02/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 0.00 2.61M 247.00K 2.44M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 2.61M 247.00K 2.44M
Selling, General, and Administrative Expenses 12.74M 10.90M 9.15M 7.20M
Research & Development 46.74M 39.00M 35.44M 20.53M
Operating Income before D & A (EBITDA) -59.48M -47.29M -44.35M -25.30M
Depreciation & Amortization 2.76M 852.00K 805.00K 940.00K
Interest Income 582.00K 234.00K 186.00K 101.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -61.65M -47.91M -44.97M -26.14M
Interest Expense 52.00K 68.00K 45.00K 284.00K
Pre-Tax Income -61.71M -47.98M -45.01M -26.42M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -58.95M -47.13M -44.21M -25.48M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -58.95M -47.13M -44.21M -25.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -58.95M -47.13M -44.21M -25.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-58.95M -47.13M -44.21M -25.48M
Preferred Dividends
Net Income Available To Common -58.95M -47.13M -44.21M -25.48M
Basic EPS from Continuing Ops. -0.63 -0.64 -0.69 -0.57
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.63 -0.64 -0.69 -0.57
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.63 -0.64 -0.69 -0.57
Basic Normalized Net Income/Share -0.63 -0.64 -0.69 -0.57
EPS fr Continuing Ops. -0.63 -0.64 -0.69 -0.57
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.63 -0.64 -0.69 -0.57
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.63 -0.64 -0.69 -0.57
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.63 -0.64 -0.69 -0.57
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACHN

Latest ACHN Headlines from TheStreet

More Financial News for ACHN

Press Releases for ACHN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter